Monmouth (OR)
{name}
{subtitle}
Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
city
~16 mi. (Salem, Oregon, +141 more cities)
facility
GSK Investigational Site
condition
Multiple Myeloma
drug
belantamab mafodotin
drug type
chemotherapy, +1 more type
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
city
~26 mi. (Corvallis, Oregon, +825 more cities)
facility
Good Samaritan Hospital
biomarker
AKT1 Mutation, +91 more biomarkers
condition
Breast Carcinoma, +3 more conditions
drug
adavosertib, +26 more drugs
drug type
immunotherapy, +1 more type
Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer
city
~26 mi. (Corvallis, Oregon, +469 more cities)
facility
Good Samaritan Hospital
condition
Non-Small Cell Lung Carcinoma
drug
carboplatin, +6 more drugs
drug type
chemotherapy, +2 more types
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
city
~26 mi. (Corvallis, Oregon, +954 more cities)
facility
Good Samaritan Hospital
condition
Non-Small Cell Lung Carcinoma
drug
crizotinib, +4 more drugs
drug type
chemotherapy, +2 more types